Full Text View
Tabular View
No Study Results Posted
Related Studies
Female Orgasmic Disorder (FOD) and Wellbutrin XL
This study is currently recruiting participants.
Study NCT00248209   Information provided by Segraves, R., T., M.D., Ph.D.
First Received: November 1, 2005   Last Updated: January 25, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Orgasmic Disorder
Additional conditions recognized in this trial
Disease
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Sexual and Gender Disorders
Interventions listed in this trial
Wellbutrin XL
Additional drug interventions recognized in this trial
Bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Segraves, R., T., M.D., Ph.D.
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services